Clinical trial NCT06849557: Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home
Official title: Effectiveness of Chair-bound Exergaming on Physical and Cognitive Functions in Pre-frail/ Frail Older Adults in Nursing Home: A Pilot Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Frailty in Older Adults
Lead sponsor: Hong Kong Metropolitan University
Sponsor class: OTHER
First posted: 2025-02-27
Enrollment: 30
Sex: ALL
Minimum age (years): 60
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: OTHER

Brief summary: This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents

Detailed description: Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents.

To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.

Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.

All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.

1. Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks.
2. Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.

Eligibility criteria: Inclusion Criteria:

* older adults aged 60 years or older living in the nursing homes;
* pre-frail or frail according to the Fried Frailty Phenotypes;
* ability to understand and execute instructions; and
* ability to sit unassisted on a chair or in a wheelchair.

Exclusion Criteria:

* no controlled medical diagnosed of severe cardiometabolic, respiratory and musculoskeletal disorders;
* any conditions that hinder the participation of intervention and assessment; and
* being involved in any other clinical trials.

Primary outcomes:
measure: upper extremity endurance
timeFrame: T0: baseline
measure: upper extremity endurance
timeFrame: T1: 6 week
measure: upper extremity endurance
timeFrame: T2: immediately (1 week) after intervention
measure: enjoyment
timeFrame: T0: baseline
measure: enjoyment
timeFrame: T1: 6 week
measure: enjoyment
timeFrame: T2: immediately (1 week) after intervention
Secondary outcomes:
measure: upper extremity strength
timeFrame: T0: baseline
measure: upper extremity strength
timeFrame: T1: 6 week
measure: upper extremity strength
timeFrame: T2: immediately (1 week) after intervention
measure: lung capacity
timeFrame: T0: baseline
measure: lung capacity
timeFrame: T1: 6 week
measure: lung capacity
timeFrame: T2: immediately (1 week) after intervention
measure: sitting balance
timeFrame: T0: baseline
measure: sitting balance
timeFrame: T1: 6 week
measure: sitting balance
timeFrame: T2: immediately (1 week) after intervention
measure: feasibility, acceptability and appropriateness of intervention
timeFrame: T2: immediately (1 week) after intervention
measure: mental health
timeFrame: T0: baseline
measure: mental health
timeFrame: T1: 6 week
measure: mental health
timeFrame: T2: immediately (1 week) after intervention
measure: cognitive function
timeFrame: T0: baseline
measure: cognitive function
timeFrame: T1: 6 week
measure: cognitive function
timeFrame: T2: immediately (1 week) after intervention
Other outcomes:
Locations:
city: Kowloon
country: Hong Kong
facility: Hiu Kwong (Tak Yue) Nursing Centre
Study officials:
References: